abrdn Life Sciences Investors remains a buy for high-yield seekers, offering a 10.1% dividend yield and diversified healthcare exposure. HQL trades at a 7.92% discount to NAV, with its share price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

HQL offers a 14.2% dividend yield and diverse exposure to healthcare and life science companies. Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price ...

The entire tech world is debating the consequences of artificial intelligence and the part AI is going to play in shaping our future. While we might think that artificial intelligence is at least a ...

Abstract: A combination of query-by-visual-example (QBVE) and semantic retrieval (SR), denoted as query-by-semantic-example (QBSE), is proposed. Images are labeled with respect to a vocabulary of ...

PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, ...

Abstract: Composed query image retrieval task aims to retrieve the target image in the database by a query that composes two different modalities: a reference image and a sentence declaring that some ...